{"id":173,"date":"2020-05-13T17:20:42","date_gmt":"2020-05-13T17:20:42","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=173"},"modified":"2020-05-13T17:20:42","modified_gmt":"2020-05-13T17:20:42","slug":"12-may-2020-tocilizumab-onset-to-tocilizumab-administration-may-be-critical-to-patient-recovery","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/12-may-2020-tocilizumab-onset-to-tocilizumab-administration-may-be-critical-to-patient-recovery\/","title":{"rendered":"(12 May 2020) Tocilizumab- onset to tocilizumab administration may be critical to patient recovery"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p>(12 May 2020) Tocilizumab- onset to tocilizumab administration may be critical to patient recovery<\/p>\n<p>Early outcomes of tocilizumab in adults hospitalized with severe COVID-19 \u2013 2 SUBTITLE: An initial report from the Vall d\u2019Hebron COVID-19 prospective cohort 3 study.<\/p>\n<p><a href=\"https:\/\/doi.org\/10.1101\/2020.05.07.20094599\">https:\/\/doi.org\/10.1101\/2020.05.07.20094599<\/a><\/p>\n<p>This preliminary report from the Vall d\u2019Hebron COVID-19 Prospective Cohort Study describes the characteristics and clinical outcomes of patients who were hospitalized in non-ICU wards and received treatment with tocilizumab. Their results show that a timely administration of immune-modulating therapies, before the onset of respiratory insufficiency or ARDS, can improve severe COVID-19 patients\u2019 outcomes with a threefold reduction in 7-day mortality.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>(12 May 2020) Tocilizumab- onset to tocilizumab administration may be critical to patient recovery Early outcomes of tocilizumab in adults hospitalized with severe COVID-19 \u2013 2 SUBTITLE: An initial report from the Vall d\u2019Hebron COVID-19 prospective cohort 3 study. https:\/\/doi.org\/10.1101\/2020.05.07.20094599&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/12-may-2020-tocilizumab-onset-to-tocilizumab-administration-may-be-critical-to-patient-recovery\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(12 May 2020) Tocilizumab- onset to tocilizumab administration may be critical to patient recovery&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[4,18],"tags":[27],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/173"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=173"}],"version-history":[{"count":2,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/173\/revisions"}],"predecessor-version":[{"id":279,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/173\/revisions\/279"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=173"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=173"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}